Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis
K. Reich, A. Blauvelt, A. Armstrong, R. G. Langley, T. Fox, J. Huang, C. Papavassilis, E. Liang, P. Lloyd, G. Bruin
科研成果: 期刊稿件 › 文章 › 同行评审
52
引用
（Scopus）